Johnson & Johnson names ChemT Biotechnology, Hill Research, Prima Mente, Waypoint Bio as QuickFire Challenge awardees, allocates USD 400,000 grants

Johnson & Johnson

JNJ

0.00

Johnson & Johnson Innovation-JJDC named ChemT Biotechnology, Hill Research, Prima Mente, Waypoint Bio as awardees in its Data & AI R&D QuickFire Challenge.
Awardees to split USD 400,000 in grant funding; selected teams may also receive JLABS Singapore membership.
ChemT Biotechnology highlighted for a virtual-cell digital twin for biomanufacturing; Prima Mente for multi-omic foundation models to identify therapeutic targets.
Hill Research cited for its TriClick agentic AI to automate clinical biometrics workflows; Waypoint Bio for spatial-biology data generation for AI disease models.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson Innovation-JJDC Inc. published the original content used to generate this news brief on July 20, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.